Teva settles shareholder lawsuit over generic drug | Business Insurance
Teva, with a $4.25B opioid settlement in hand, eyes return to growth by 2027 | Fierce Pharma
Teva faces class-action lawsuit over US antitrust probe into price-fixing | The Times of Israel
Teva_Pharmaceuticals | ערוץ 7
Allergan, Teva to pay $54M in San Francisco opioid lawsuit | The Seattle Times
Teva Stock Pressured From Antitrust Lawsuit Against Drug Makers | Barron's
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva lied about opioid role, New York says | Reuters
US states accuse Teva and other drugmakers of colluding to inflate prices over 1,000%
Pharmaceutical Company Reaches Settlement With Oklahoma In Opioid Case : NPR
Teva Pharmaceuticals, NY reach opioid lawsuit settlements worth $523M - Top Class Actions
Teva to pay $523m. to New York as it looks to move past opioid lawsuits - The Jerusalem Post
Report: Teva settles investor lawsuit for $420M - www.israelhayom.com
Teva Pharmaceutical says it will defend claims it was involved in price-fixing in the US
Teva Pharmaceuticals - Wikipedia
Teva ponies up $420M to settle with investors who said company hid price-fixing scheme | Fierce Pharma
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York State | CNN
Teva, Israel's Biggest Country, In Opioid Legal Trouble
Teva to pay New York $500M for role in opioid crisis - POLITICO
States allege generic drug manufacturers conspired to artificially inflate prices in lawsuit
Teva Pharmaceuticals found liable in New York opioid trial - BBC News
Teva expects to start paying U.S. opioid settlement in 2023 | Reuters
